MARC LUSTGARTEN PANCREATIC CANCER
Data sourced from IRS 990 public filings
MARC LUSTGARTEN PANCREATIC CANCER THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD.THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD, FUNDING PREEMINENT PANCREATIC CANCER RESEARCHERS, DRIVING THE PURSUIT OF BOLD AND INNOVATIVE SCIENCE TOWARD EARLIER DETECTION AND BETTER TREATMENTS TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FUNDS RESEARCH WHERE CREATIVE RISKS YIELD HIGH REWARDS TO ACCELERATE AND EXPAND LIFE-SAVING TREATMENT OPTIONS. WE BELIEVE TIME IS EVERYTHING TO PATIENTS AND THEIR FAMILIES, AND THAT COMMUNITY IS POWER. LUSTGARTEN PROGRAMS AND EVENTS PROVIDE PEOPLE AFFECTED BY PANCREATIC CANCER A VOICE AND A PLACE TO CREATE HOPE, TOGETHER. THROUGH FY24, THE LUSTGARTEN FOUNDATION HAS INVESTED $287.2 MILLION IN PANCREATIC CANCER RESEARCH.
MARC LUSTGARTEN PANCREATIC CANCER has received 319 grants from 173 known foundation funders. Revenue increased from $22,749,028 in 2023 to $37,190,710 in 2024. Most recent reported revenue: $37,190,710.
Annual Revenue
$37,190,710
Known Funders
173
Grants Received
319
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $37,190,710 | $27,180,092 | $91,535,774 |
| 2023 | $22,749,028 | $30,962,554 | $75,802,153 |
| 2022 | $18,297,575 | $28,681,699 | $78,560,475 |
| 2021 | $30,446,505 | $33,834,657 | $78,505,397 |
| 2020 | $24,467,833 | $21,726,029 | $96,561,632 |
| 2019 | $14,966,634 | $24,862,781 | $90,551,380 |
| 2018 | $29,500,163 | $29,535,726 | $99,323,748 |
| 2017 | $44,255,198 | $23,085,254 | $105,061,017 |
Top Funders
Wilmington, DE
BLOOMFIELD HILLS, MI
WEST PALM BEACH, FL
PROVIDENCE, RI
WEST PALM BEACH, FL
SOUTHEASTERN, PA
SOUTHEASTERN, PA
NEW YORK, NY
WEST PALM BEACH, FL
Showing top 10 of 173 funders.
Key Personnel
From 2024 IRS 990 filing
SUSAN M JACOBSON
DIRECTOR EXTERNAL & COMMUNITY RELATIONS
STEPHANIE DERGARABEDIAN
NATIONAL DIRECTOR OF DEVELOPMENT
JACLYN P LYMAN
HEAD CLINICAL RESEARCH & DEVELOPMENT
GLEN PECK
SVP TECHNOLOGY & BUSINESS INTELLIGENCE
ANDREW RAKEMAN
VP RESEARCH
FAISAL JAWAID
CFO
KERRI KAPLAN
PRESIDENT
LINDA TANTAWI
CEO
RICHARD R BARAKAT MD MBA
DIRECTOR
AARON KANTOFF
DIRECTOR
Showing 10 of 24 key personnel.
Frequently Asked Questions
Other Nonprofits in New York
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.